Description:
Dexlansoprazole is a proton pump inhibitor that is marketed by Takeda Pharmaceuticals for the treatment of erosive esophagitis and gastro-oesophageal reflux disease
- Molecular Weight:369.36
- Melting Point:>78°C
- Purity:>98%
Molecular Formula:
C16H14F3N3O2S
Canonical SMILES:
CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
InChI:
InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m1/s1
InChIKey:
MJIHNNLFOKEZEW-RUZDIDTESA-N
Solubility:
0.21mg/mL at pH7.0
Appearance:
Brown solid
Application:
Anti-Ulcer Agents
Synonyms:
T 168390; TAK 390; T168390; TAK390; T-168390; TAK-390; Dexlansoprazole; Dexilant; Kapidex; TAK-390MR; TAK 390MR; TAK390MR Más detalles se encuentran
aquí